Breast Lesion Localization Market is Estimated to Reach USD 2,021.527 Million by the end of 2028: Cognitive Market Research

Market Overview:
Breast lesion localization is a medical tool for detecting both malignant and non-malignant tumors in the breast. Breast lesion causes an abnormal alteration in the breast tissue produced by illnesses or traumas that affects around 20% of female patients. However, as breast imaging methods such as MRI, ultrasound, or mammography was conducted in small fraction of the patients in these series, this percentage is likely to be an understatement of the real incidence of breast lesions. Breast localization techniques are required in up to 50% of all lumpectomy and surgical biopsy operations to ensure correct removal of the target lesion.
There are several types of breast lesion localization procedures utilized across the world to detect a lump or tumor in the breast. Preoperative image-guided localization of breast lesions is a standard practice. The commonly available localization options include wire localization, radioisotope localization, electromagnetic localization, localization with a radiofrequency reflector, and magnetic localization.

Market Insight:
• Global Breast Lesion Localization Market is expected to reach USD 2,021.527 Million by the end of 2028, growing at a CAGR of 9.36% between 2021 and 2028.
• Wire-guided Localization Revenue is anticipated to reach at USD 714.51 Million in 2028
• Hospitals Revenue in Breast Lesion Localization is expected to reach USD 1,256.22 Million in 2028.
• Fine Needle Aspiration Revenue in Breast Lesion Localization is projected to reach USD 607.32 Million in 2028.
• Tumor Identification Revenue in Breast Lesion Localization is estimated to reach USD 1,305.77 Million in 2028.
• North America Breast Lesion Localization market size is anticipated USD 719.22Million in 2028.

To know more The Breast Lesion Localization Market statistics click here: https://www.cognitivemarketresearch.com/breast-lesion-localization-market-report

Market Drivers:
Rising prevalence of breast cancer
Cancer is one of the most leading causes of deaths across the globe. Breast cancer is the second leading cause of cancer death in women. It has been noted that breast cancer is the most common type of cancer among women. According to some studies, average risk of a woman in the United States developing breast cancer sometime in her life is about 13%. This means there is a 1 in 8 chance she will develop breast cancer. Prevalence of breast cancer is due to combination of factors. The main factors that influence this cancer include being a woman.
According to WHO, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally in year 2020. Breast cancer can present in a wide variety of
ways, which is why a complete medical examination is important. Hence, it is important that women with persistent abnormalities should undergo tests including imaging of the breast and in some cases tissue sampling (biopsy) to determine if a mass is malignant (cancerous) or benign.
Rise in geriatric population
• Restraints for Breast Lesion Localization Market
High cost associated with complete procedure
• Opportunities for Breast Lesion Localization Market
Technological advancements in medical field

Market Segmentation:
Type:
• Wire-guided Localization
A wire localization is a treatment that involves marking the exact site of a tumour or anomaly with a tiny wire. Preoperative histological diagnosis is possible with ultrasound-guided percutaneous biopsy or stereotactic biopsy of a breast lesion. Several approaches for detecting non-palpable breast tumours have been presented, but the wire-guided localization (WGL) technique is the most often used. Wire-guided localization (WGL) is the oldest and most extensively utilized approach for removing nonpalpable beast lesions. This method is simple to conduct under ultrasound or mammography guidance, and it allows for real-time control of the wire-needle position, allowing for precise lesion localization.

• Radioactive Seed Localization
Preoperative localization is critical for the most effective surgical treatment of breast lesions, especially those that are not palpable. For nonpalpable breast lesions, radioactive seed localization (RSL) utilizing iodine-125 which is a relatively novel method that can be used instead of wire localization. These seeds do not move after being placed in order to offer appropriate surgical guidance. Furthermore, radioactive seed localization is a reliable preoperative localization approach for breast tumours
with little seed movement, regardless of in-situ duration. It is a simple and efficient method that improves patient care coordination.

• Non-radioactive Radar Localization
• Magnetic Seed

Uses:
• Tumor Identification
Breast cancer diagnosis has evolved over the last few years. Breast lesion localisation is a cutting-edge technique for detecting benign and malignant cancers in breast images during screening and diagnosis. Breast cancer increases the need for therapeutic methods by increasing the frequency of malignant tumours in women. It aids surgeons and radiologists in the detection of tumours and also serves as a marketplace for surgical treatments.

• Sentinel Lymph Node Identification
When cancer spreads, the first lymph node to be impacted is the sentinel node. The preoperative method of identifying lymph nodes is used to eliminate the primary cancer cells. These sentinel lymph nodes were detected using breast lesion localization equipment. The modified sentinel node and occult lesion localization (SNOLL) approach, which uses a single nano colloidal radiotracer injection, has a high intraoperative sentinel lymph node identification rate

Technique:
• Fine Needle Aspiration
FNA, also known as fine needle biopsy, is a form of biopsy in which a needle is introduced into a lump or mass to get a sample of cells. It is one of several methods for identifying breast masses other than surgical removal. Fine needle aspiration uses a technique for obtaining tissue and fluid samples from solid or cystic breast lesions using a small (21 to 25 gauge) needle. With a thin needle similar to those used for blood testing, a breast fine needle aspiration (FNA) extracts some fluid or cells from a breast lesion (a cyst, lump, sore, or swelling). A specialized doctor examines a sample of fluid or cells.

• Biopsy Core Needle
A breast lump that is visible on a mammography or ultrasound, or that doctor feels during a clinical breast exam, may be assessed with a core needle biopsy. A radiologist or surgeon removes tissue samples from the breast lump using a narrow, hollow needle. Several samples are taken and analyzed, each roughly the size of a grain of rice. The needle is either aimed directly at the location of a palpable lesion (freehand biopsy) or an imaging approach such as ultrasound-guided core needle biopsy and MRI-guided core needle biopsy is used to locate the target lesion. Core needle biopsy had a lower risk of complications than open surgical biopsy.
 
• Biopsy Image-guided Biopsy

End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Get free sample pages of latest published Breast Lesion Localization Report: https://www.cognitivemarketresearch.com/breast-lesion-localization-market-report

Competitive Analysis for Breast Lesion Localization Market:
D. Company, Cianna Medical, Cook Medical, Becton, Dickinson and Company , Endomagnetics Ltd, Health Beacon , Intramedicalimaging, Devicor Medical Products, Inc , Somatex Medical Technologies GmbH, Surgiceye GmbH , Ranfac Corporation

• Becton, Dickinson and Company
BD is medical technology company that has adopted advancement in the manufacturing of medical devices, diagnostic, delivery of care. Company provides innovative solutions that helps advance medical research and genomics, enhance diagnosis of disease, cancer, optimizes medication management, promote infection prevention, and equip surgical and interventional procedure, supports management of diabetes. BD Technologies and innovation in Research Triangle Park in North Carolina develops next-generation technologies including advanced diagnostics, computer-aided engineering technology develops innovative, optimized, robust products utilizing CAE technologies, genomic sciences, smart data and science technologies, and this increases its value in the market.

NEWS:
March 2021
• BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings
BD company has acquired GSL solutions, a privately held company that developed smart medication devices for the storage and tracking of controlled substance. and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including of controlled substances, regulatory compliance and patient safety.

• SurgicEye GmbH
SurgicEye GmbH is a solution and service provider for nuclear medicine guided therapies. It offers several products to healthcare professionals including declipse SPECT Open surgery, declipse SPECT imaging probe and others. The company serves its products worldwide including Europe, USA, Latin America, GCC and Asia Pacific.

Related Report:
• Breast Cancer Screening Market- https://www.cognitivemarketresearch.com/breast-cancer-screening-market-report
• Breast MRI Screening System Market- https://www.cognitivemarketresearch.com/breast-mri-screening-system-market-report
• Breast Lesion Guidance Systems Market- https://www.cognitivemarketresearch.com/breast-lesion-guidance-systems-market-report
• Breast Lesion Localization Devices Market-https://www.cognitivemarketresearch.com/breast-lesion-localization-devices-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.